NCT00818402

Brief Summary

The principal objective is to study clinical observations, symptoms and quality of life of non-small-cell lung cancer (NSCLC) patients undergoing specific non-operative treatment for cancer, including chemotherapy and radiotherapy.

Trial Health

100
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
130

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Aug 2008

Typical duration for all trials

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

August 1, 2008

Completed
5 months until next milestone

First Submitted

Initial submission to the registry

January 5, 2009

Completed
2 days until next milestone

First Posted

Study publicly available on registry

January 7, 2009

Completed
3.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 1, 2012

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

February 1, 2012

Completed
Last Updated

May 29, 2015

Status Verified

May 1, 2015

Enrollment Period

3.5 years

First QC Date

January 5, 2009

Last Update Submit

May 28, 2015

Conditions

Non Small Cell Lung Cancer

Keywords

Quality of lifesymptoms

Study Arms (1)

Non-small cell lung cancer patients

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

The patients treated in the clinic of respiratory medicine in Turku, Finland

You may qualify if:

  • Patients with verified NSCLC
  • after the NSCLC diagnosis has been confirmed prior to first chemotherapy or radiotherapy
  • Finnish speaking patients
  • aged 18 years or more
  • Written informed consent has to be signed

You may not qualify if:

  • Patients not consenting to participate in the study
  • patients not able to communicate sufficiently
  • cancer type is other than non-small-cell lung cancer

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Biospecimen

Retention: SAMPLES WITH DNA

whole blood

MeSH Terms

Conditions

Carcinoma, Non-Small-Cell Lung

Condition Hierarchy (Ancestors)

Carcinoma, BronchogenicBronchial NeoplasmsLung NeoplasmsRespiratory Tract NeoplasmsThoracic NeoplasmsNeoplasms by SiteNeoplasmsLung DiseasesRespiratory Tract Diseases

Study Design

Study Type
observational
Observational Model
CASE ONLY
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
MD

Study Record Dates

First Submitted

January 5, 2009

First Posted

January 7, 2009

Study Start

August 1, 2008

Primary Completion

February 1, 2012

Study Completion

February 1, 2012

Last Updated

May 29, 2015

Record last verified: 2015-05